Celeste Lebbé

30PUBLICATIONS

226CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jul 02, 2026

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jul 08, 2025

RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|Jul 04, 2025

Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800).

Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera

|May 19, 2025

The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target.

Ikuan Sam, Nadine Ben Hamouda, Marina Alkatrib

|Mar 28, 2025

A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.

Oliver Bechter, Carmen Loquai, Stephane Champiat

|Mar 28, 2025

Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma.

Ikuan Sam, Nadine Benhamouda, Lucie Biard

Pageof 5

Frequent Collaborators

11 joint publications

Paolo A Ascierto

Caroline Robert

Georgina V Long

Reinhard Dummer

Dirk Schadendorf

Jean-Jacques Grob

Piotr Rutkowski

Vanna Chiarion-Sileni

4 joint publications

Maxime Battistella

4 joint publications

Helen Gogas

Frequent Collaborators

11 joint publications

Paolo A Ascierto

9 joint publications

Caroline Robert

8 joint publications

Georgina V Long

7 joint publications

Reinhard Dummer